Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials | Europ Jour of Clinical Pharma https://t.co/dAyMIBjOVK
@RichardAFerraro Interestingly, in this open label trial, it seems that the possible benefit of beta blocker continuation is driven by the cardiac hospitalizations piece of the composite end point…
The Study of the Week Is A Study That Did Not Happen
My thoughts on the cancellation of the RECOVER IV trial. It's a story of hubris and duality of interests
https://t.co/yZZm7ZM6mM
EQs occurring at median depth of ~3.5 mi (5.7 km) below sea level, about ~4.6 mi (7.4 km) below the crater floor. Small magnitude EQs located beneath #MountStHelens at these depths generally thought to be associated with arrival of additional magma, a process called recharge.